Onconic Therapeutics - Current Ratio

The Current Ratio as of August 2026 (TTM) for Onconic Therapeutics (476060.KQ) is 11.39

According to Onconic Therapeutics’s latest financial reports and current stock price. The company's current Current Ratio is 11.39. This represents a change of -11.88% compared to the average of 12.93 of the last 4 quarters.

Onconic Therapeutics (476060.KQ) Historical Current Ratio (quarterly & annually)

How has 476060.KQ Current Ratio performed in the past?

The mean historical Current Ratio of Onconic Therapeutics over the last ten years is 13.25. The current 11.39 Current Ratio has changed 8.50% with respect to the historical average. Over the past ten years (40 quarters), 476060.KQ's Current Ratio was at its highest in in the December 2025 quarter at 17.62. The Current Ratio was at its lowest in in the June 2023 quarter at 0.

Onconic Therapeutics (476060.KQ) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Onconic Therapeutics Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Onconic Therapeutics (476060.KQ) Average Current Ratio

How has 476060.KQ Current Ratio performed in the past?

The current Current Ratio of Onconic Therapeutics (476060.KQ) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Onconic Therapeutics (476060.KQ) Current Ratio vs. Peers

How is 476060.KQ’s Current Ratio compared to its peers?

Onconic Therapeutics’s Current Ratio is greater than Macrogen, Inc. (0.85), less than MedPacto, Inc. (23.06), greater than Amicogen, Inc. (1.04), greater than GeneOne Life Science, Inc. (0.46), less than IMBdx (15.87), greater than EASY BIO,Inc. (1.23), greater than Encell Co. Ltd. (9.07), less than GC Genome Corporation (0), greater than CG Invites Co., Ltd. (0.34), greater than HANDOK Inc. (0.86),

Build a custom stock screener for Onconic Therapeutics (476060.KQ) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Onconic Therapeutics using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Onconic Therapeutics (476060.KQ) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Onconic Therapeutics or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.